Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

BACKGROUND: The survival advantage of induction chemotherapy (IC) followed by locoregional treatment is controversial in locally advanced head and neck squamous cell carcinoma (LAHNSCC). We previously showed feasibility and safety of cetuximab-based IC (paclitaxel/carboplatin/cetuximab—PCC, and doce...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Oncol
Main Authors: Haddad, R.I., Massarelli, E., Lee, J.J., Lin, H.Y., Hutcheson, K., Lewis, J., Garden, A.S., Blumenschein, G.R., William, W.N., Pharaon, R.R., Tishler, R.B., Glisson, B.S., Pickering, C., Gold, K.A., Johnson, F.M., Rabinowits, G., Ginsberg, L.E., Williams, M.D., Myers, J., Kies, M.S., Papadimitrakopoulou, V.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Head and neck tumor
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360148/
https://ncbi.nlm.nih.gov/pubmed/30596812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy549
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki